GHR Foundation
  • Impact Areas
    • Global Engagement >
      • Children in Families
      • Prepare The Future
      • Programs in Transition >
        • BridgeBuilder >
          • Overview
          • 2017 Top Ideas >
            • Peace Direct
            • BioCarbon Engineering
            • LIFT Chicago
            • Local Youth Corner Cameroon
            • NaTakallam
          • 2018 Top Ideas >
            • This is My Backyard
            • Found in Translation
            • Producers Direct
            • War Child Canada
            • My Choices Foundation
          • 2019 Top Ideas >
            • Top Manta
            • Five One Labs
            • SAMA for All
            • Talent Beyond Boundaries
            • FaithAction
        • Inter-Religious Action
        • Sister Support
    • Catholic Education
    • Twin Cities Racial Equity (TCRE)
    • Alzheimer's Initiative
  • News
  • About Us
    • The Foundation
    • History & Legacy
    • Team >
      • Staff
      • Committees
      • Board
    • FAQs
    • Grants & Financials
  • Contact

GHR Partner Religions for Peace Supporting Multi-Religious Actions on COVID-19 in 20 countries

8/21/2020

0 Comments

 
Picture
Image: Religions for Peace
Religions for Peace’s Multi-Religious Humanitarian Fund, seed-funded by GHR, is bringing together diverse religious leaders, communities, and institutions through affiliated Interreligious Councils to provide critical humanitarian response in the wake of COVID-19. The MRHF is currently financing 20 projects in 20 countries, and RfP announced a new round of applications on August 19th, World Humanitarian Day.

Funded projects were selected based on a track record of interreligious collaboration and experience providing humanitarian relief. Creative proposals raising resources to scale up services, partner with other religious and civic groups, and ensure sustainability of efforts were specifically sought.

Read more...
0 Comments

GHR Commits $1M to COVID-19 Therapeutics Accelerator

8/11/2020

0 Comments

 
Picture
GHR is partnering boldly as we work to address the long-term effects of the COVID-19 pandemic on our partners and communities. Via a $1 million gift, the Foundation joins the Bill & Melinda Gates Foundation, Mastercard Impact Fund and Wellcome in supporting a collaborative effort to research, develop and bring effective COVID-19 treatments to market quickly and accessibly.  

Building off the momentum across public and private sectors to achieve optimal outcomes for therapeutic solutions, the COVID-19 Therapeutics Accelerator (CTA) aims to fill gaps in the R&D ecosystem, remove barriers to drug development and scale up treatments to address the pandemic, particularly in low-resource settings. CTA is committed to equitable access, ensuring that supported innovations are available and affordable to all.  

The immediate focus of this initiative is to develop therapies that mitigate the impact of COVID-19 and can be made available within this year, while leaving a sustainable infrastructure in place for the long term, ensuring future epidemic and pandemic preparedness.  
0 Comments

Partnering Boldly with La Jolla Institute for Immunology on COVID-19 Research

8/3/2020

1 Comment

 
UPDATE 09/17/20: On August 20th, Dr. Saphire's  presented GHR-sponsored work to the Neutralizing Antibody Summit held by Operation Warp Speed. Dr. Francis Collins, the Director of the National Institutes of Health, and all of Operation Warp Speed and NIH are now relying on the data by the La Jolla Institute for Immunology.

GHR is honored to provide $1 million in support of the Coronavirus Immunotherapy Consortium (CoVIC), a global partnership headquartered at the La Jolla Institute for Immunology (LJI). Led by Dr. Erica Ollmann Saphire, Ph.D., a professor in LJI’s Center for Infectious Disease and Vaccine Research, CoVIC aims to accelerate the discovery, optimization, and delivery of life-saving antibody-based therapeutics against SARS-CoV-2, the virus that causes COVID-19. 

“As the COVID-19 pandemic has shown clearly, infectious disease anywhere becomes infectious disease everywhere. Until a vaccine becomes available, we need a way of giving people immediate immunity,” says Dr. Saphire, “and antibody therapy is the way to do it. The support of GHR will help us expand and accelerate the analysis of antibodies from people who have recovered from COVID-19, to understand how they work and deliver the best ones across the globe.” 
GHR LJI Partnership Press Release
File Size: 77 kb
File Type: pdf
Download File

1 Comment

    Categories

    All
    A4
    Alzheimer's
    Alzheimer's Association
    BridgeBuilder
    C2N
    Catholic Schools
    Children In Families
    COVID-19
    Develop Diagnostics
    DIAN Primary Prevention
    DIAN-TU
    Education
    Global Development
    Higher Education
    Inter-Religious Action
    La Jolla Institute
    Mayo Clinic
    Mayo Clinic Study Of Aging
    NIH-NIA
    Observational Studies
    Prepare The Future
    Prevention Trials
    Sister Support
    Twin Cities Racial Equity

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    December 2018
    November 2018
    October 2018
    September 2018
    June 2018
    May 2018
    April 2018
    February 2018
    January 2018
    November 2017
    October 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    January 2017
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    August 2014
    July 2014
    May 2014
    April 2014
    March 2014
    October 2013
    December 2012

    RSS Feed

CONNECT WITH US

IMPACT AREAS  |  NEWS  |  ABOUT  |  JOBS  | ​ CONTACT  
Privacy Policy  |  Terms of Use
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
©2023 GHR FOUNDATION
All Rights Reserved.